Owlstone Medical announces investment of up to $2.3 million USD from the Cystic Fibrosis Foundation to develop a breath test for Pseudomonas aeruginosa detection in cystic fibrosis patients

Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced that the Cystic Fibrosis Foundation has made an up to…

Continue ReadingOwlstone Medical announces investment of up to $2.3 million USD from the Cystic Fibrosis Foundation to develop a breath test for Pseudomonas aeruginosa detection in cystic fibrosis patients

Groundbreaking initiative launched to tackle environmental risks facing children

University of Oklahoma researchers recently launched the Children's Environmental Health Center in the U.S. Southern Great Plains, a groundbreaking initiative dedicated to advancing research on children's health and environmental exposures,…

Continue ReadingGroundbreaking initiative launched to tackle environmental risks facing children